SYNTAX III Revolution: A randomized study to evaluate the feasibility of Heart-Team clinical decision making regarding the optimal (surgical or percutaneous based) revascularization strategy in patients with complex coronary artery disease.

Read more >

Dessolve III is a prospective, single-blind (patient), randomized, controlled, multicenter trial. Approximately 17 sites in Europe will participate.
Read more >

TALENT is a prospective multicenter randomized post market all-comer trial to assess the safety and effectiveness of the SUPRAFLEX ...

Read more > 

ABSORB STEMI: the TROFI II Study is one of the first randomized clinical trials which compares the durable polymer based everolimus-eluting XIENCE with the bioresorbable everolimus-eluting...
Read more >

The GLOBAL LEADERS trial is an Investigator-Sponsored Study (ISS) in which 16,000 “all-comer” patients are enrolled in 131 centers in 18 countries in Europe, Australia, Brazil, Canada & Singapore.
Read more >

ECRI provides a structure facilitating trials without the overhead however with the required clinical trial execution expertise.

read more >

SYNTAX II is a European multicenter single-arm study investigating the effectiveness of a new generation stent ....

read more >

A randomized comparison of a rivaroxaban-based strategy with an antiplatelet-based strategy following successful TAVR for the prevention of leaflet thickening and reduced leaflet motion. 

Read more >